BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 4073093)

  • 1. In vitro activity and in vivo evaluation of ticarcillin plus clavulanic acid against aerobic and anaerobic bacteria.
    Bansal MB; Chuah SK; Thadepalli H
    Am J Med; 1985 Nov; 79(5B):33-8. PubMed ID: 4073093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of penicillin or ticarcillin in combination with clavulanic acid in the treatment of experimental intra-abdominal abscess.
    Bansal MB; Prabahala R; Thadepalli H
    J Antimicrob Chemother; 1986 Feb; 17(2):221-6. PubMed ID: 3700288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation effect of clavulanic acid with penicillin, cephalothin and ticarcillin against Bacteroides fragilis.
    Bansal MB; Chuah SK; Oryema-Lalobo M; Thadepalli H
    Chemotherapy; 1985; 31(3):173-7. PubMed ID: 3996086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial activity of ticarcillin in the presence of clavulanate potassium.
    Sutherland R; Beale AS; Boon RJ; Griffin KE; Slocombe B; Stokes DH; White AR
    Am J Med; 1985 Nov; 79(5B):13-24. PubMed ID: 3878080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antibacterial activities of ticarcillin alone and ticarcillin plus clavulanic acid against beta-lactamase producing and non-producing microorganisms.
    Hsueh PR; Chang SC; Chen YC; Hsu LY; Luh KT; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Aug; 25(3):149-59. PubMed ID: 1342000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro susceptibilities of 504 bacteremic isolates to ticarcillin plus clavulanic acid and other antimicrobial agents.
    Rotstein C; Amsterdam D; Beam T; Gorzynski E
    Diagn Microbiol Infect Dis; 1989; 12(2):157-63. PubMed ID: 2752713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centers.
    Barry AL; Ayers LW; Gavan TL; Gerlach EH; Jones RN
    Eur J Clin Microbiol; 1984 Jun; 3(3):203-6. PubMed ID: 6147246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of ticarcillin plus clavulanic acid in the treatment of infections of soft tissue, bone, and joint.
    Johnson CC; Reinhardt JF; Wallace SL; Terpenning MS; Helsel CL; Mulligan ME; Finegold SM; George WL
    Am J Med; 1985 Nov; 79(5B):136-40. PubMed ID: 4073081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: a multicenter study.
    Fuchs PC; Jones RN; Barry AL; Allen SD; Aldridge KE; Gerlach EH; Sommers HM
    Diagn Microbiol Infect Dis; 1988 Jan; 9(1):47-50. PubMed ID: 3370931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antibacterial activity of ticarcillin/clavulanic acid (BRL28500) against ticarcillin-resistant bacteria.
    Kasai T; Nishino T; Kazuno Y; Tanino T
    J Antibiot (Tokyo); 1986 Oct; 39(10):1450-60. PubMed ID: 3536827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacies of ticarcillin, ticarcillin/clavulanic acid, piperacillin and cefoxitin against polymicrobial infections in mice caused by Escherichia coli and Bacteroides fragilis.
    Beale AS; Gisby J
    Infection; 1991; 19(2):101-5. PubMed ID: 2050417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ticarcillin plus clavulanic acid versus moxalactam in the treatment of skin and soft tissue infections.
    Rao B; See RC; Chuah SK; Bansal MB; Lou MA; Thadepalli H
    Am J Med; 1985 Nov; 79(5B):126-9. PubMed ID: 4073078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of gram-negative bacteria and Staphylococcus aureus to combinations of ticarcillin and clavulanic acid.
    Casey P; Glauser M
    Eur J Clin Microbiol; 1983 Dec; 2(6):541-7. PubMed ID: 6607834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo.
    Boon RJ; Beale AS; Sutherland R
    Antimicrob Agents Chemother; 1986 May; 29(5):838-44. PubMed ID: 3524431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative activity of ticarcillin-clavulanic acid and various beta-lactams against Pseudomonas maltophilia].
    Monteil H; Jehl F
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):805-8. PubMed ID: 3309818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of infections in hospitalized patients with ticarcillin plus clavulanic acid. A comparative study.
    Holloway WJ
    Am J Med; 1985 Nov; 79(5B):168-71. PubMed ID: 4073086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ticarcillin plus clavulanic acid with cefoxitin in the treatment of female pelvic infection.
    Pastorek JG; Aldridge KE; Cunningham GL; Faro S; Graffeo S; McNeeley GS; Tan JS
    Am J Med; 1985 Nov; 79(5B):161-3. PubMed ID: 4073084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal effects of amoxycillin/clavulanic acid and ticarcillin/clavulanic acid in in-vitro kinetic models.
    White AR; Stokes DH; Slocombe B; Sutherland R
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():227-32. PubMed ID: 3980328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clavulanic acid in combination with ticarcillin: an in-vitro comparison with other beta-lactams.
    Clarke AM; Zemcov SJ
    J Antimicrob Chemother; 1984 Feb; 13(2):121-8. PubMed ID: 6323375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticarcillin plus clavulanic acid in the treatment of patients with cancer.
    Fainstein V; Elting L; Pitlik S; Hortobagyi G; Keating M; Bodey GP
    Am J Med; 1985 Nov; 79(5B):62-6. PubMed ID: 4073096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.